144 related articles for article (PubMed ID: 36823311)
21. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.
Xu C; Liu Y; Jiang D; Li Q; Ge X; Zhang Y; Huang J; Su J; Ji Y; Hou J; Lu S; Hou Y; Liu T
Oncotarget; 2017 May; 8(20):33185-33196. PubMed ID: 28388541
[TBL] [Abstract][Full Text] [Related]
22. Combining expression of RNF43 and infiltration level of CD163
Zhu D; Shi X; Tian Y; Li H; Tang B; Zhang Z; Zhang Z; Zuo L
Cancer Med; 2023 Feb; 12(4):3962-3971. PubMed ID: 36097369
[TBL] [Abstract][Full Text] [Related]
23. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract][Full Text] [Related]
25. RNF43 Inhibits Cancer Cell Proliferation and Could be a Potential Prognostic Factor for Human Gastric Carcinoma.
Niu L; Qin HZ; Xi HQ; Wei B; Xia SY; Chen L
Cell Physiol Biochem; 2015; 36(5):1835-46. PubMed ID: 26184844
[TBL] [Abstract][Full Text] [Related]
26. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
27. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition.
Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B
Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269
[TBL] [Abstract][Full Text] [Related]
28. Identification of a high-risk subtype of intestinal-type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion.
Aoyama T; Hutchins G; Arai T; Sakamaki K; Miyagi Y; Tsuburaya A; Ogata T; Oshima T; Earle S; Yoshikawa T; Grabsch HI
Cancer Med; 2018 Oct; 7(10):4914-4923. PubMed ID: 30160049
[TBL] [Abstract][Full Text] [Related]
29. The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications.
Heckl SM; Wiesener V; Behrens HM; Ulase D; Krüger S; Röcken C
Gastric Cancer; 2019 Nov; 22(6):1130-1142. PubMed ID: 30989432
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer.
Lu YJ; Wu CS; Li HP; Liu HP; Lu CY; Leu YW; Wang CS; Chen LC; Lin KH; Chang YS
Genes Chromosomes Cancer; 2010 May; 49(5):412-24. PubMed ID: 20095042
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
Röcken C; Behrens HM; Böger C; Krüger S
J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
[TBL] [Abstract][Full Text] [Related]
33. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
[TBL] [Abstract][Full Text] [Related]
34. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
[TBL] [Abstract][Full Text] [Related]
35. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
36. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF
Elez E; Ros J; Fernández J; Villacampa G; Moreno-Cárdenas AB; Arenillas C; Bernatowicz K; Comas R; Li S; Kodack DP; Fasani R; Garcia A; Gonzalo-Ruiz J; Piris-Gimenez A; Nuciforo P; Kerr G; Intini R; Montagna A; Germani MM; Randon G; Vivancos A; Smits R; Graus D; Perez-Lopez R; Cremolini C; Lonardi S; Pietrantonio F; Dienstmann R; Tabernero J; Toledo RA
Nat Med; 2022 Oct; 28(10):2162-2170. PubMed ID: 36097219
[TBL] [Abstract][Full Text] [Related]
37. RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.
Zhu L; Shi H; Li P; Zhang P
Ann Clin Lab Sci; 2023 Jan; 53(1):21-29. PubMed ID: 36889779
[TBL] [Abstract][Full Text] [Related]
38. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases.
Jiang X; Charlat O; Zamponi R; Yang Y; Cong F
Mol Cell; 2015 May; 58(3):522-33. PubMed ID: 25891077
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
40. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features.
Park SY; Kook MC; Kim YW; Cho NY; Jung N; Kwon HJ; Kim TY; Kang GH
Virchows Arch; 2010 Oct; 457(4):415-22. PubMed ID: 20737169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
